Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease
about
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individualsA Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLDType 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the SpotlightPharmacological Preconditioning by Adenosine A2a Receptor Stimulation: Features of the Protected Liver Cell PhenotypeStress management: How the unfolded protein response impacts fatty liver diseaseTargeting autophagy for the treatment of liver diseasesThe adipokine/ceramide axis: key aspects of insulin sensitizationInfiltrating monocytes in liver injury and repairTumor progression and the different faces of the PERK kinaseMolecular mechanisms of liver injury and hepatocarcinogenesis: focusing on the role of stress-activated MAPKInflammation- and stress-related signaling pathways in hepatocarcinogenesisDifference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in miceThe Mammalian "Obesogen" Tributyltin Targets Hepatic Triglyceride Accumulation and the Transcriptional Regulation of Lipid Metabolism in the Liver and Brain of ZebrafishThe Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in MiceInsulin Protects Hepatic Lipotoxicity by Regulating ER Stress through the PI3K/Akt/p53 Involved Pathway Independently of Autophagy InhibitionMechanisms of fibrosis: therapeutic translation for fibrotic disease4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics.Evolving therapies for liver fibrosis.Nonalcoholic Fatty liver disease, diabetes mellitus and cardiovascular disease: newer data.High fat feeding induces hepatic fatty acid elongation in mice.Fenofibrate simultaneously induces hepatic fatty acid oxidation, synthesis, and elongation in mice.Effects of resveratrol in experimental and clinical non-alcoholic fatty liver diseaseRole of thiazolidinediones, insulin sensitizers, in non-alcoholic fatty liver diseaseAcyl-CoA synthesis, lipid metabolism and lipotoxicity.PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid omega-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver DiseaseFat content, fatty acid pattern and iron content in livers of turkeys with hepatic lipidosis.Impaired PI3K/Akt signal pathway and hepatocellular injury in high-fat fed rats.Effects of body weight and alcohol consumption on insulin sensitivityMolecularly defined unfolded protein response subclasses have distinct correlations with fatty liver disease in zebrafish.Developmental origins of nonalcoholic fatty liver diseaseMolecular pathways in non-alcoholic fatty liver disease.High fat diet induced hepatic steatosis and insulin resistance: Role of dysregulated ceramide metabolism.α-Linolenic acid prevents endoplasmic reticulum stress-mediated apoptosis of stearic acid lipotoxicity on primary rat hepatocytesTranslational approaches: from fatty liver to non-alcoholic steatohepatitis.Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine modelGLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy.Exendin-4 Improves Nonalcoholic Fatty Liver Disease by Regulating Glucose Transporter 4 Expression in ob/ob Mice.Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease.A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitisHepatocyte death: a clear and present danger.
P2860
Q22299426-967A50A7-94F3-462D-A30C-DAC1BE727463Q26752487-BACF8CB7-23E6-4B38-AA88-E17D1C2ADD08Q26752583-1B348D5D-2D9C-492C-BF1D-920A8C89339CQ26779198-89AE6640-5036-498D-B554-39DE66082252Q27009277-26C69930-64BE-476D-8204-087267578971Q27014838-CA304D97-5FA8-4D5E-B7F5-C59628B00D49Q27025041-00D7EBBE-14F4-4788-A9FF-7FE8BB9162D5Q28070341-5EDB2043-04BE-40BC-81EF-791289282C70Q28087036-83968124-3073-4C75-8E60-BB0B14E25023Q28384866-D765E12F-AB0E-47B6-B225-5027743FD03EQ28387669-9DFAC585-8B9C-4242-B612-B85715720B72Q28507402-9ADB039F-779F-45D0-BB3F-D833D93E1B10Q28551300-6AE43CF0-52D0-457E-95BF-F4364BA7C9A3Q28552063-B6166F0E-0D72-401F-90C4-D038F86B5475Q28834030-CA39962B-68B2-403A-AB0A-D367E0F292EBQ29620307-E1DB137C-9327-48D6-B881-6FAE547DF5AEQ30412771-EEECA469-ACC0-4274-8006-0C6F06203D92Q30539166-746108EA-A767-4E07-ADC5-42C34A604C77Q30622511-165EF82E-BD2A-4C69-A3FB-35ED8B2A72F1Q33474784-1F69F813-0167-48BD-9370-10FE33065394Q33553422-36F2CFC9-0299-4E13-B3C0-58F573C6E1E1Q33563877-C4F1F4BE-5764-4FF4-ABAC-275E08D8108DQ33607697-9146F0CC-2FA3-46C2-AA49-C745070F29BAQ33665741-4FD50B9A-D4C8-42C5-AFAE-E38DB3E799BEQ33734125-37C04336-F381-42D3-8FC9-9F0DD97DB388Q33743274-6C4CACFF-DD33-448E-8E4B-8CFB543347C5Q33779364-3D6CA38D-849E-4E10-BAF9-979055475EC0Q33810797-B33C7B83-6111-4B50-93CA-5F6676E80239Q33814245-47B377E8-CA2C-4A30-9AB8-044D81942FC3Q33844787-9F35837C-5098-4376-AB67-48D5587C8A10Q33890230-E466F62D-0F19-4919-A44D-48A31A2EAD67Q33896110-3B3DAB90-6133-45A7-AAAD-11D7EDCF8F4BQ33904744-3776FA20-164F-4EB0-84C7-5C61E38C08E2Q33958697-B66AD684-D387-46C3-891E-9A2E0A8AF95CQ33998998-7E2B1AA7-1FBE-417D-A57D-BF8094CA0134Q34034795-A4E6F0FF-F9BB-43C9-9C46-F49E6E3D90EEQ34097903-E7CB6E1D-613B-4A91-8E6F-608CEB3990A5Q34103693-84C228B1-12A1-4AA7-8FFA-8AA91C20A78BQ34131187-465ECAEB-BB91-4C67-9653-C2FD54033B6EQ34147508-B9FB743F-778F-42C2-93B0-579035D459BF
P2860
Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease
@en
Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease.
@nl
type
label
Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease
@en
Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease.
@nl
prefLabel
Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease
@en
Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease.
@nl
P2860
P356
P1476
Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease
@en
P2093
Harmeet Malhi
P2860
P304
P356
10.1055/S-0028-1091980
P577
2008-10-27T00:00:00Z